FMR CORP 13D/13G Filings for Janux Therapeutics, Inc. (JANX)

FMR CORP 13D and 13G filings for Janux Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-12
10:32 am
Purchase		 2024-11-08 13G Janux Therapeutics, Inc.
JANX		 FMR CORP 7,824,674
14.999%		 3,153,461increase
(+67.51%)		 Filing
2024-02-09
09:16 am
Sale		 2024-02-08 13G Janux Therapeutics, Inc.
JANX		 FMR CORP 4,671,213
10.117%		 -934,647decrease
(-16.67%)		 Filing
2023-02-09
11:18 am
Purchase		 2023-02-09 13G Janux Therapeutics, Inc.
JANX		 FMR CORP 5,605,860
13.455%		 614,458increase
(+12.31%)		 Filing
2022-01-10
1:26 pm
Purchase		 2022-01-07 13G Janux Therapeutics, Inc.
JANX		 FMR CORP 4,991,402
11.995%		 4,991,402increase
(New Position)		 Filing